Tue, May 21, 2013, 8:35 PM EDT - U.S. Markets closed
Likely to be the Stock of the Year.
TTNP has a 6 month implant to treat the drug addiction epidemic.
Millions are addicted to ilicit drugs and pain meds.
The FDA granted TTNP priority review.
The approval decision will be made on April 30.
Approval earns TTNP a $50,000,000 milestone plus tiered double digit royalties.
Pick up some shares before April.
This one looks really good......not your typical spam.
I might take a shot.